Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSpirax-Sarco Regulatory News (SPX)

Share Price Information for Spirax-Sarco (SPX)

Share Price is delayed by 15 minutes
Get Live Data
6,695.00    0.00 (0.00%)
Bid:
0.00
Ask:
0.00
Spread: 10.00 (0.15%)
Market Cap: £4.94b
SPX Live PriceLast checked at - London Stock Exchange

Intraday Spirax-Sarco Share Chart

Acquisition

25 May 2010 13:30

RNS Number : 5064M
Spirax-Sarco Engineering PLC
25 May 2010
 



 

 

Spirax-Sarco Engineering plc

 

Charlton House

Cheltenham

Glos. GL53 8ER

 

 

News Release

 

 

Telephone: 01242 521361

Fax: 01242 581470

www.SpiraxSarcoEngineering.com

 

25th May 2010

 

 

Spirax Sarco acquires remaining 51% equity in Mexican Associate Company for £10.7 million 

 

Spirax-Sarco Engineering plc announces that it has acquired from its local partners the remaining 51% voting equity in its Mexican operating company, Spirax-Sarco Mexicana S.A. ("Spirax Mexico"), which was previously 49% owned by the Group and accounted as an Associate.

 

Spirax Mexico has been Spirax Sarco's exclusive licensee and distributor for Mexico since 1980, successfully growing the business and establishing Spirax Sarco as the market leader. We are pleased to gain full control in this strategically important market that has the 13th largest economy in the world and the 11th largest population. The Mexican industrial steam‑using base, that is Spirax Mexico's target market, is expected to provide good future growth prospects as we invest and increase focus in this developing market.

 

The purchase consideration for the 51% of Spirax Mexico not previously controlled by the Group is MX$201.9 million (£10.7 million), which will be settled in instalments over an expected five year period from existing Group resources. It is anticipated that the business will have net cash balances in excess of £1m at Closing. Trading has started well in 2010 and we expect the transaction to make a small positive contribution to Group earnings in the second half of 2010.

 

Accounting changes

Under the provisions of amended IFRS3, which will apply to the Group for 2010, the results of Spirax Mexico will, with effect from 25th May 2010 onwards, be fully consolidated with sales and operating profit included in the Americas segment in the Group results. Up to this date, Spirax Mexico will continue to be accounted for as an Associate with 49% of the after-tax profit for this period included within Associates in the Group Income Statement. In addition, as required by IFRS3, the 2010 Group accounts will reflect the uplift in the current book value of the Group's existing 49% investment, which will be shown as an exceptional profit of approximately £8 million in the Group Income Statement.

 

About Spirax Sarco

Spirax-Sarco Engineering plc provides a broad range of fluid control products, engineered packages, site services and systems expertise for its diverse range of over 100,000 industrial and institutional customers. The Company helps its customers to optimise production capacity, reduce energy costs and emissions, improve product quality and enhance the safety of their operations. Spirax Sarco is headquartered in Cheltenham, England, has strategically located manufacturing plants around the world and employs approximately 4,200 people, of whom 1,200 are direct sales and service engineers. Its shares have been listed on the London Stock Exchange since 1959 (symbol: SPX). Further information can be found at www.spiraxsarcoengineering.com.

 

 

Contact details:

 

Mark Vernon - Chief Executive

David Meredith - Director Finance

 

 

Spirax-Sarco Engineering plc

Charlton House

Cheltenham

Gloucestershire

GL53 8ER

 

Tel: 01242 535234

Fax: 01242 581470

www.SpiraxSarcoEngineering.com

 

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
ACQEAASSAANEEFF
Date   Source Headline
8th Jun 20261:24 pmRNSDirector/PDMR Shareholding
1st Jun 202610:28 amRNSChange in Major Shareholding
29th May 20262:24 pmRNSUpdate on Directorships held by Company Directors
27th May 20263:30 pmRNSDirector/PDMR Shareholding
26th May 20265:24 pmRNSDirector/PDMR Shareholding
19th May 20269:16 amRNSChange in Major Shareholding
14th May 20262:47 pmRNSExternal Directorships held by Company Directors
14th May 202610:39 amRNSDirector/PDMR Shareholding
13th May 20264:12 pmRNSResult of AGM
13th May 20267:00 amRNSTrading Update
8th May 20263:42 pmRNSChange in Major Shareholding
7th May 20269:03 amRNSDirector/PDMR Shareholding
8th Apr 20262:22 pmRNSDirector/PDMR Shareholding
8th Apr 20269:30 amRNSAnnual Report and Accounts 2025 and Notice of AGM
18th Mar 20264:53 pmRNSDirector/PDMR Shareholding
11th Mar 20261:53 pmRNSTotal Voting Rights
10th Mar 20265:01 pmRNSDirector/PDMR Shareholding
10th Mar 20267:00 amRNS2025 Full Year Results
10th Mar 20267:00 amRNS2025 Full Year Results
9th Mar 20263:35 pmRNSDirector/PDMR Shareholding
9th Mar 20263:35 pmRNSDirector/PDMR Shareholding
10th Feb 20269:30 amRNSChange in Director Details
6th Feb 20263:47 pmRNSDirector/PDMR Shareholding
2nd Feb 20261:50 pmRNSChange in Director Details
30th Jan 20262:19 pmRNSHolding(s) in Company
6th Jan 20263:10 pmRNSDirector/PDMR Shareholding
18th Dec 20252:12 pmRNSCorrection: Block Listing Application
18th Dec 20252:12 pmRNSCorrection: Block Listing Application
18th Dec 202510:34 amRNSBlocklisting Application
9th Dec 20252:35 pmRNSDirector/PDMR Shareholding
18th Nov 20259:40 amRNSDirector/PDMR Shareholding
13th Nov 20257:00 amRNSTrading Update
7th Nov 20251:56 pmRNSDirector/PDMR Shareholding
5th Nov 20258:39 amRNSHolding(s) in Company
22nd Oct 20257:00 amRNSBoard Appointment
7th Oct 20255:08 pmRNSDirector/PDMR Shareholding
9th Sep 20257:00 amRNSDirector/PDMR Shareholding
1st Sep 20259:35 amRNSHolding(s) in Company
12th Aug 20257:00 amRNSBoard Committee Membership Update
12th Aug 20257:00 amRNS2025 Half Year Results
7th Aug 20257:00 amRNSDirector/PDMR Shareholding
24th Jul 20254:58 pmRNSDirector/PDMR Shareholding
9th Jul 20254:26 pmRNSDirector/PDMR Shareholding
13th Jun 20253:36 pmRNSDirector/PDMR Shareholding
14th May 20254:48 pmRNSResult of AGM
14th May 20257:00 amRNSTrading Update
8th May 202511:03 amRNSDirector/PDMR Shareholding
23rd Apr 20255:13 pmRNSChange in Director Details
22nd Apr 20253:52 pmRNSDirector/PDMR Shareholding
11th Apr 20255:04 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.